ElexoPharm


ElexoPharm
is a company providing services for medicinal chemistry research for the pharmaceutical industry. We are focused on the discovery and optimisation of new drugs. Furthermore ElexoPharm runs an own drug development programme resulting in licence offers.

From Hit to Lead


The name is program. In order to obtain highly active and selective compounds with a convenient pharmacokinetic profile we are able to identify and to optimise the first biologically active hit compounds faster and more efficiently than others due to our long lasting experience in rational drug design. This ensures a quick development of new lead compounds.

Top Issues

ElexoPharm enters into cardiovascular collaboration with Merck & Co., Inc. More

ElexoPharm appoints Prof. Jürgen Engel as Chairman of the Advisory Board. More

Are you looking for an experienced partner to provide support in the preclinical drug development process? More

References